Longaeva Partners’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$23.8M Buy
+361,821
New +$27.6M 0.49% 42

Other funds holding CYTK

Longaeva Partners's CYTK Position: Q3 2026 in Review

Longaeva Partners opened a new position in Cytokinetics (CYTK) in Q3 2026: 361,821 shares worth $23.8M. The stake represents 0.49% of the portfolio and ranks #42 among its holdings.

472 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.

  • Longaeva Partners held 361,821 shares of Cytokinetics worth $23.8M as of Q3 2026.
  • Cytokinetics was a new Longaeva Partners position in Q3 2026.
  • Cytokinetics made up 0.49% of Longaeva Partners's portfolio in Q3 2026, its #42 holding.
  • 472 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.

Based on Longaeva Partners's 13F filing for Q3 2026, filed 16 Nov 2026.